Recent Quarter Total Invested
$460.28 M
Recent Quarter Institutional Ownership Percentage
78.58%
Total Invested of Last Quarter
$384.85 M
Ownership Percentage of Last Quarter
97.66%
Allogene Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TPG GP A, LLC | 11/14/2024 | 18.72 M | $52.41 B | 0.00% | 8.95% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 17.77 M | $49.76 M | 100.00% | 8.50% |
| STATE STREET CORP | 11/14/2024 | 7.01 M | $19.64 M | -8.54% | 3.35% |
| CAPITAL WORLD INVESTORS | 11/13/2024 | 6.90 M | $19.31 M | 0.00% | 3.30% |
| LYNX1 CAPITAL MANAGEMENT LP | 11/14/2024 | 6.20 M | $17.37 B | 178.35% | 2.97% |
| PRIMECAP MANAGEMENT CO/CA/ | 11/08/2024 | 5.67 M | $15.87 M | -0.03% | 2.71% |
| CITADEL ADVISORS LLC | 11/14/2024 | 5.04 M | $14.11 M | 105.99% | 2.41% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 4.84 M | $13.55 M | -16.44% | 2.31% |
| WOODLINE PARTNERS LP | 11/14/2024 | 4.36 M | $12.22 M | 0.12% | 2.09% |
| JPMORGAN CHASE & CO | 11/08/2024 | 4.09 M | $11.45 M | -0.91% | 1.95% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 3.23 M | $9.04 M | 14.43% | 1.54% |
| WILDCAT CAPITAL MANAGEMENT, LLC | 11/08/2024 | 2.92 M | $8.18 B | 0.00% | 1.40% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 2.87 M | $8.03 M | 0.00% | 1.37% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 2.80 M | $7.83 M | -5.50% | 1.34% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 2.73 M | $7.65 M | 7.05% | 1.31% |
| PERCEPTIVE ADVISORS LLC | 11/14/2024 | 2.73 M | $7.63 M | 0.00% | 1.30% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 2.41 M | $6.75 M | 7.49% | 1.15% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 2.16 M | $6.06 M | 41.34% | 1.03% |
| VIDA VENTURES ADVISORS, LLC | 10/08/2024 | 1.80 M | $5.03 M | 0.00% | 0.86% |
| MORGAN STANLEY | 11/14/2024 | 1.72 M | $4.82 M | -20.19% | 0.82% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/12/2024 | 1.63 M | $4.58 M | 461.58% | 0.78% |
| VESTAL POINT CAPITAL, LP | 11/14/2024 | 1.50 M | $4.20 M | -31.82% | 0.72% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.18 M | $3.30 M | 0.04% | 0.56% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.05 M | $2.94 M | 73.54% | 0.50% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 677,140 | $1.97 M | -15.29% | 0.32% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 642,009 | $1.80 M | -63.27% | 0.31% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 583,925 | $1.63 M | 34.95% | 0.28% |
| ZACKS INVESTMENT MANAGEMENT | 11/14/2024 | 516,601 | $1.45 M | 100.00% | 0.25% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/13/2024 | 486,023 | $1.36 M | 1.17% | 0.23% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 11/14/2024 | 478,115 | $1.34 M | -30.70% | 0.23% |
| NORDEA INVESTMENT MANAGEMENT AB | 11/05/2024 | 451,006 | $1.30 M | -28.94% | 0.22% |
| CERITY PARTNERS LLC | 11/12/2024 | 432,382 | $1.21 M | 0.05% | 0.21% |
| COASTAL BRIDGE ADVISORS, LLC | 11/14/2024 | 405,847 | $1.14 M | -0.25% | 0.19% |
| UBS GROUP AG | 11/14/2024 | 347,340 | $972,552 | 15.66% | 0.17% |
| BARCLAYS PLC | 11/19/2024 | 342,973 | $959,000 | 101.48% | 0.16% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 317,619 | $889,334 | -12.35% | 0.15% |
| RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 316,946 | $887,449 | -45.81% | 0.15% |
| SWISS NATIONAL BANK | 11/07/2024 | 264,900 | $741,720 | -7.70% | 0.13% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 258,002 | $722,406 | 43.63% | 0.12% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 11/05/2024 | 254,845 | $713,566 | -43.97% | 0.12% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 254,239 | $711,869 | 6.35% | 0.12% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 247,564 | $694,552 | -6.34% | 0.12% |
| CAXTON ASSOCIATES LP | 11/14/2024 | 242,102 | $677,886 | -48.06% | 0.12% |
| MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 11/08/2024 | 236,696 | $662,749 | -3.76% | 0.11% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 210,078 | $588,218 | 0.00% | 0.10% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 199,421 | $558,379 | 21.94% | 0.10% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 188,497 | $527,792 | 48.86% | 0.09% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 177,113 | $495,917 | -47.61% | 0.08% |
| ALPS ADVISORS INC | 11/12/2024 | 175,285 | $490,798 | 7.63% | 0.08% |
| RHUMBLINE ADVISERS | 11/12/2024 | 174,187 | $487,717 | 5.88% | 0.08% |
Allogene Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of ALLO shares?
During the previous two years, 193 institutional investors and hedge funds held shares of Allogene Therapeutics, Inc.. The most heavily invested institutionals were:
TPG GP A, LLC: 18.72 M
BlackRock Funding, Inc. /DE: 17.77 M
STATE STREET CORP: 7.01 M
Capital World Investors: 6.9 M
Lynx1 Capital Management LP: 6.2 M
PRIMECAP MANAGEMENT CO/CA/: 5.67 M
-
What percentage of Allogene Therapeutics, Inc. stock is owned by institutional investors?
78.58% of Allogene Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at ALLO ?
Institutional investors have bought a total of 162.01 M shares in the last 24 months. This purchase volume represents approximately $358.03 M in transactions.